| Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda. (NCT05801198) | King Faisal Hospital Rwanda | 2024-03-01 |
| Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis (NCT06582940) | Sun Yat-sen University | 2024-03-01 |
| Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus (NCT05253768) | Zhujiang Hospital | 2024-03-01 |
| Complement C5 mAb in the Treatment of Anti-GBM Disease (NCT06513338) | Peking University First Hospital | 2024-03-01 |
| Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy (NCT06957379) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-02-29 |
| Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis (NCT06835361) | AVVA Pharmaceuticals Ltd. | 2024-02-29 |
| Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML (NCT06434662) | First Affiliated Hospital of Zhejiang University | 2024-02-29 |
| Local Dishes Versus Ready-to-use Therapeutic Foods Management of Severe Acute Malnutrition (NCT06759883) | University of Garoua | 2024-02-29 |
| Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) (NCT06231381) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-02-29 |
| Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) (NCT06085729) | M.D. Anderson Cancer Center | 2024-02-29 |
| Gene Therapy for ACM Due to a PKP2 Pathogenic Variant (NCT06109181) | Lexeo Therapeutics | 2024-02-29 |
| Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury (NCT06302582) | Liaocheng People's Hospital | 2024-02-29 |
| Effect of Nutritional Ketosis on Alcohol Metabolism (NCT06065657) | University of Pennsylvania | 2024-02-29 |
| Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) (NCT06272487) | Alnylam Pharmaceuticals | 2024-02-29 |
| The PENTO Protocol in Medication-related Osteonecrosis of the Jaw (NCT05795647) | University Hospital, Limoges | 2024-02-29 |
| Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II (NCT06195189) | Sichuan University | 2024-02-29 |
| A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) (NCT06335173) | Acumen Pharmaceuticals | 2024-02-29 |
| Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury (NCT06548802) | Tianjin Medical University General Hospital | 2024-02-29 |
| GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma (NCT05913388) | Providence Health & Services | 2024-02-29 |
| Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions (NCT06271564) | Ain Shams University | 2024-02-29 |
| A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye (NCT06296966) | Vanda Pharmaceuticals | 2024-02-29 |
| A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies (NCT06131450) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-02-29 |
| Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) (NCT06242691) | Merck Sharp & Dohme LLC | 2024-02-28 |
| Mesotherapy Treatment of Irritable Bowel Syndrome (NCT06261320) | Polyclinique de l'Europe | 2024-02-28 |
| Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer (NCT06055465) | Chinese University of Hong Kong | 2024-02-28 |
| AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer (NCT04556253) | Peking University | 2024-02-28 |
| Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade (NCT06238245) | Beijing 302 Hospital | 2024-02-28 |
| Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption (NCT06137248) | University of Florida | 2024-02-28 |
| Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment (NCT05926700) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-02-28 |
| Repurposing Valsartan May Protect Against Pulmonary Hypertension (NCT06053580) | University of Washington | 2024-02-28 |
| A Study in Patients With Mixed Dyslipidemia (NCT06497127) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2024-02-28 |
| A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma (NCT06126237) | Keymed Biosciences Co.Ltd | 2024-02-28 |
| Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer (NCT06329973) | Henan Cancer Hospital | 2024-02-28 |
| A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only) (NCT06112275) | Encoded Therapeutics | 2024-02-28 |
| Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring (NCT05500391) | Centre Oscar Lambret | 2024-02-28 |
| Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency (NCT06237205) | Korea University Anam Hospital | 2024-02-27 |
| A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI (NCT06533358) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2024-02-27 |
| Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis (NCT06477406) | Mclean Hospital | 2024-02-27 |
| A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors (NCT06208124) | Immuneering Corporation | 2024-02-27 |
| A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) (NCT06196879) | Upstream Bio Inc. | 2024-02-27 |
| Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke (NCT04903951) | Philips Portuguesa S.A. | 2024-02-27 |
| Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders (NCT06321796) | Gut-Brain-Axis Therapeutics Inc. | 2024-02-27 |
| Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea (NCT06312813) | Wright State University | 2024-02-27 |
| The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases (NCT06252454) | University Hospital Hradec Kralove | 2024-02-27 |
| Heart Failure Polypill at a Safety Net Hospital (NCT06029712) | University of California, San Francisco | 2024-02-27 |
| A Study of Pasireotide in People With Prolactinoma (NCT06295952) | Memorial Sloan Kettering Cancer Center | 2024-02-27 |
| Effect of Vitamin D Injection on Hypertrophic Scars and Keloids (NCT06301178) | Mostafa Bahaa | 2024-02-27 |
| Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) (NCT06319287) | Rion Inc. | 2024-02-27 |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT06161025) | Daiichi Sankyo | 2024-02-27 |
| Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation (NCT06106308) | Cardiff Oncology | 2024-02-27 |
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT06172478) | Daiichi Sankyo | 2024-02-26 |
| Combining Stellate Ganglion Block With Prolonged Exposure for PTSD (NCT05889741) | The University of Texas Health Science Center at San Antonio | 2024-02-26 |
| Control Systems Engineering for Weight Loss Maintenance (NCT06244888) | The Miriam Hospital | 2024-02-26 |
| A Study of RAY1225 in Participants With Type 2 Diabetes (NCT06254274) | Guangdong Raynovent Biotech Co., Ltd | 2024-02-26 |
| Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis (NCT06176508) | Hansoh BioMedical R&D Company | 2024-02-26 |
| AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) (NCT06245915) | Arsenal Biosciences, Inc. | 2024-02-26 |
| Open-label Placebo in Manual Therapy (NCT06306742) | Studio Osteopatico Busto Arsizio | 2024-02-26 |
| Efficacy of Noisome as A Carrier of Locally Delivered Minocycline Hydrochloride Gel (NCT06255067) | Ain Shams University | 2024-02-25 |
| Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA (NCT06222944) | Peking University | 2024-02-25 |
| Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) (NCT05940324) | Stanford University | 2024-02-24 |
| TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer (NCT06293014) | Henan Cancer Hospital | 2024-02-23 |
| Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) (NCT05986864) | Skyline Therapeutics (US) Inc. | 2024-02-23 |
| Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery (NCT06290193) | Memorial Sloan Kettering Cancer Center | 2024-02-23 |
| A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) (NCT06282159) | Dianthus Therapeutics | 2024-02-23 |
| Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . (NCT06250946) | Shandong Suncadia Medicine Co., Ltd. | 2024-02-23 |
| Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients (NCT06071013) | China Medical University Hospital | 2024-02-23 |
| Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer) (NCT05787639) | University of California, San Diego | 2024-02-23 |
| DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy (NCT06221748) | RemeGen Co., Ltd. | 2024-02-22 |
| Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant (NCT05424003) | University of Virginia | 2024-02-22 |
| A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors (NCT06271837) | AstraZeneca | 2024-02-22 |
| Caffeine Use in the Management of Preterm Infants (NCT06327152) | University of California, Irvine | 2024-02-22 |
| A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC (NCT06241846) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2024-02-22 |
| Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer (NCT07334431) | Henan Cancer Hospital | 2024-02-22 |
| Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) (NCT05925530) | AstraZeneca | 2024-02-22 |
| The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer (NCT06254521) | First Affiliated Hospital of Guangxi Medical University | 2024-02-22 |
| A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma. (NCT06232096) | Beijing Mabworks Biotech Co., Ltd. | 2024-02-22 |
| NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) (NCT05996003) | NS Pharma, Inc. | 2024-02-22 |
| Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors (NCT06301828) | Nanjing First Hospital, Nanjing Medical University | 2024-02-21 |
| A Study of RAY1225 in Participants With Obesity (NCT06254261) | Guangdong Raynovent Biotech Co., Ltd | 2024-02-21 |
| Behavioral Exercise Training to Reduce Cardiovascular Disease Risk (NCT06237179) | Virginia Commonwealth University | 2024-02-21 |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma (NCT06277154) | HRYZ Biotech Co. | 2024-02-21 |
| Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation (NCT06706388) | n-Lorem Foundation | 2024-02-21 |
| A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity (NCT06226090) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-02-21 |
| Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement (NCT06572904) | Mansoura University | 2024-02-20 |
| Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma (NCT05896228) | Benjamin T Diamond, MD | 2024-02-20 |
| Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial (NCT06236295) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-02-20 |
| A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis (NCT06280391) | Sanofi | 2024-02-20 |
| A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab（AK104） for Newly Diagnosed Local Advanced Cervical Cancer (NCT06251388) | West China Second University Hospital | 2024-02-20 |
| JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure (NCT05998408) | National Heart, Lung, and Blood Institute (NHLBI) | 2024-02-20 |
| Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension (NCT05647473) | Fujian Medical University Union Hospital | 2024-02-20 |
| MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men (NCT06031428) | Medical College of Wisconsin | 2024-02-20 |
| GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors (NCT06265025) | GeneMedicine Co., Ltd. | 2024-02-20 |
| A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever (NCT06006559) | Novartis Pharmaceuticals | 2024-02-20 |
| A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis (NCT06260709) | Novo Nordisk A/S | 2024-02-20 |
| A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma (NCT05736406) | Hemerion Therapeutics | 2024-02-20 |
| HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis (NCT06213519) | Sichuan University | 2024-02-20 |
| A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery (NCT06210490) | Peking University First Hospital | 2024-02-20 |
| A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) (NCT06185764) | Vertex Pharmaceuticals Incorporated | 2024-02-20 |
| Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer (NCT06222879) | Shandong Suncadia Medicine Co., Ltd. | 2024-02-20 |
| Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. (NCT06218602) | M.D. Anderson Cancer Center | 2024-02-19 |